While most contents have already been covered during previous webinars there were a few more details regarding CHM 1101 and the CAR-T logistics presented, at least some I wasn't aware of.
CHM got its vector requirements for the CDH 17 clinical trials sorted but the market ignored it completely while over at ALA just a new prototype started a buying frenzy.
Looking forward to the GBM read outs in about 8 months time, Jason cementing the ability and therefore a real possibility of killing all brain cancer cells at the end of Q&A.
JC as always a stellar presenter, if she would do it for IMU too it would take IMU's Proactive videos to the next level imo. I admire LC as well but JC is just brilliant in that regard.
What is CHM's MC again?
GLTA
CHM Price at posting:
7.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)